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January 19, 2010:255–69nto an ischemic area results in modulation of the local tissue
mmune system and altered cytokine production (4). Indeed, BMC
ransplantation results in local inflammatory changes that activate
yofibroblasts, thus reducing infarct size (5). Thus, modulation of
ro- and anti-inflammatory intramyocardial cytokine levels by
ransplanted cells and their crosstalk with the local tissue environ-
ent likely affect survival and differentiation of progenitor cells, as
ell as overall cardiac outcome.
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eply
he letter by Drs. Thum and Anker touches various aspects of
ardiac stem cell therapy (e.g., mortality, paracrine effects, and
nflammation), all of which may be briefly addressed as follows.
Intracoronary stem cell therapy seems to represent a safe and
ffective regimen for treatment of heart failure after acute myocar-
ial infarction (1,2), in an old myocardial infarction (8 years)
ith ischemic cardiomyopathy (3), and in advanced dilated car-
iomyopathy (4). Our study (5) did not aim to speculate (Drs.
hum and Anker) on stem cell-induced inflammation (which has
ot yet been documented in the overwhelming majority of studies)
nd on possible paracrine effects by stem cells, but fortunately was
ble to analyze the different parameters of ventricular performance
nd potential effects on cardiac mortality in large patient groups,
reated and untreated, in long-term follow-up after myocardial
nfarction.
When carefully reading our paper (5), the BALANCE (Clinical
enefit and Long-Term Outcome After Intracoronary Autologous
one Marrow Cell Transplantation in Patients With Acute
yocardial Infarction) study showed that mortality, as a conse-
uence of stem cell therapy, is significantly reduced; in a median
ollow-up time of 4.6  2.1 years in the bone marrow cell group ppatient died, and in 4.8  2.2 years, 7 patients in the control
roup died (p  0.03).
Mortality is dependent on both the degree of ventricular
mpairment and the amount of arrhythmogenicity. Dependent on
he multifactorial mode of action of stem cells, systolic function
e.g., ejection fraction, stroke volume, contractility) and diastolic
erformance are improved; infarct size, end-systolic volume, and
ystolic wall stress decrease; and the arrhythmogenicity of the heart
s presumably reduced. Thus, several of the main myocardial
eterminants of cardiac mortality are influenced in favor of reduced
ortality by stem cell treatment in chronically ill cardiac patients.
Undoubtedly, further large studies are needed to analyze the
ction of stem cells on ventricular performance and cardiac
ortality in different stages of chronic cardiac failure, especially
ith regard to the distinct origin of this chronic disease.
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rade of Ischemia to Assess
o Reflow After Reperfusion
e read with great interest the excellent review by Niccoli et al. (1)
bout the no-reflow phenomenon in humans. In their paper, the
uthors describe various techniques for the prediction of no-reflow.
s far as electrocardiography is concerned, the authors only
ention the QRS score as a predictor of ischemia-related injury.
The extent of terminal QRS distortion on the admission
lectrocardiogram, known as the grade of ischemia, is a strong
redictor of failure of ST-segment resolution as well as of
